Home » Topics » BioWorld Science

BioWorld Science
RSS

Galderma Research & Development discloses RORC inverse agonists

Sep. 5, 2018

FDA grants IND clearance for phase II/III study of LYS-SAF-302 for MPS IIIA

Sep. 5, 2018

Palobiofarma and Novartis patent adenosine A2A receptor antagonists

Sep. 5, 2018

National Institute of Pharmaceutical R&D divulges BTK ihibitors

Sep. 5, 2018

Development of a new PDE9A inhibitor for the treatment of CNS diseases

Sep. 5, 2018

Ossianix to use BBB delivery technology with agents from Novo Nordisk

Sep. 5, 2018

Positive results reported across multiple endpoints in ZENITH-1 trial of oral BCX-7353

Sep. 5, 2018

Nerlynx approved in Europe as extended adjuvant therapy of HER2-positive early-stage breast cancer

Sep. 5, 2018

Boehringer Ingelheim and Tsinghua University to develop novel therapies against infectious diseases

Sep. 5, 2018

Additional positive data presented from phase IIa study of NasoVAX intranasal influenza vaccine

Sep. 5, 2018

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...
Grace Therapeutics hits CRL setback with GTx-104 despite positive trial
BioWorld
Grace Therapeutics Inc.’s hopes of becoming the first company in decades to update the standard of care in aneurysmal subarachnoid hemorrhage were delayed after...